关注
Dr. Gurleen Kaur Tung
Dr. Gurleen Kaur Tung
Post Doctoral Scholar, CWRU, Ohio, USA
在 gndu.ac.in 的电子邮件经过验证
标题
引用次数
引用次数
年份
Myopia, its prevalence, current therapeutic strategy and recent developments: A Review
H Singh, H Singh, U Latief, GK Tung, NR Shahtaghi, NS Sahajpal, I Kaur, ...
Indian journal of ophthalmology 70 (8), 2788-2799, 2022
192022
Sensitivity and specificity prediction of the buccal micronucleus cytome assay in end-stage renal disease patients on dialysis: A case-control study
G Gandhi, G Tung
Mutation Research/Genetic Toxicology and Environmental Mutagenesis 822, 1-9, 2017
142017
Genotoxic damage in end-stage renal disease
G Gandhi, T Mehta, P Contractor, G Tung
Mutation Research/Genetic Toxicology and Environmental Mutagenesis 835, 1-10, 2018
112018
3D‐QSAR and scaffold hopping based designing of benzo[d]ox‐azol‐2(3H)‐one and 2‐oxazolo[4,5‐b]pyridin‐2(3H)‐one derivatives as selective aldehyde …
H Verma, G Narendra, B Raju, M Kumar, SK Jain, GK Tung, PK Singh, ...
Archiv der Pharmazie 355 (9), 2200108, 2022
102022
Preparation and characterisation of liposomes of bergenia ciliata extract and evaluation of their hepatoprotective activity
U Latief, M Kaur, SH Dar, S Thakur, TS Per, GK Tung, SK Jain
Journal of Pharmaceutical Sciences 112 (1), 328-335, 2023
52023
Bergenia ciliata as a future candidate for liver diseases: a concise review
U Latief, GK Tung, H Singh, TS Per, SK Jain
The Journal of Basic and Applied Zoology 83 (1), 17, 2022
52022
Micro RNAs as emerging therapeutic targets in liver diseases
U Latief, GK Tung, TS Per, M Kaur, S Thakur, H Singh, SK Jain
Current Protein and Peptide Science 23 (6), 369-383, 2022
42022
Baseline and oxidatively damaged DNA in end-stage renal disease patients on varied hemodialysis regimens: A comet assay assessment
GK Tung, G Gandhi
Molecular and Cellular Biochemistry 479 (2), 199-211, 2024
32024
Raloxifene and bazedoxifene as selective ALDH1A1 inhibitors to ameliorate cyclophosphamide resistance: A drug repurposing approach
G Narendra, B Raju, H Verma, M Kumar, SK Jain, GK Tung, S Thakur, ...
International Journal of Biological Macromolecules 242, 124749, 2023
32023
In silico guided designing of optimized benzochalcones derivatives as potent CYP1B1 inhibitors: An integrated in vitro and ONIOM study
H Sharma, B Raju, G Narendra, M Kumar, H Verma, B Sharma, GK Tung, ...
Journal of Molecular Graphics and Modelling 119, 108390, 2023
32023
Machine learning enabled structure-based drug repurposing approach to identify potential CYP1B1 inhibitors
B Raju, G Narendra, H Verma, M Kumar, B Sapra, G Kaur, SK Jain, ...
ACS omega 7 (36), 31999-32013, 2022
32022
Association of VEGF-2549 I/D and VEGF+ 936 C/T polymorphisms with chronic Kidney disease in North-West Indian patients
GK Tung, V Sambyal, K Guleria
Indian Journal of Nephrology 32 (5), 445-451, 2022
22022
Serum Creatinine Levels, Glomerular Filtration Rate and Renal Insufficiency
GK TUNG, G GANDHI
South Asian Anthropol. 13, 9-15, 2013
22013
DNA damage in a patient with Systemic Lupus Erythematosus and Nephropathy- A Case Report
GK Tung, G Gandhi
IJBR 6 (7), 0
2*
Scaffold hopping for designing of potent and selective CYP1B1 inhibitors to overcome docetaxel resistance: synthesis and evaluation
B Raju, G Narendra, H Verma, M Kumar, B Sapra, G Kaur, SK Jain, ...
Journal of Biomolecular Structure and Dynamics, 1-19, 2024
12024
Polygenic Risk Score Assessment for Coronary Artery Disease in Asian Indians
M Rout, GK Tung, JR Singh, NK Mehra, GS Wander, S Ralhan, ...
Journal of Cardiovascular Translational Research, 1-11, 2024
2024
Scaffold hopping based designing of selective ALDH1A1 inhibitors to overcome cyclophosphamide resistance: synthesis and biological evaluation
G Narendra, B Raju, H Verma, M Kumar, SK Jain, GK Tung, S Thakur, ...
RSC Medicinal Chemistry 15 (1), 309-321, 2024
2024
1477-P: Improved Diabetes Risk Prediction Using Ancestry-Specific Polygenic Score—Results from the Asian Indian Diabetic Heart Study/Sikh Diabetes Study
GK TUNG, M ROUT, DK SANGHERA
Diabetes 72 (Supplement_1), 2023
2023
Identification of potential benzoxazolinones as CYP1B1 inhibitors via molecular docking, dynamics, waterswap, and in vitro analysis
B Raju, H Verma, G Narendra, G Kaur, SK Jain, O Silakari
New Journal of Chemistry 47 (26), 12339-12349, 2023
2023
Prognostic value of microRNA profiles in Chronic Kidney Disease: A Review
V Tung, GK., Latief, U., Jain, SK., Singh, H., Sambyal
Advances in Health and Disease 51, 167-177, 2022
2022
系统目前无法执行此操作,请稍后再试。
文章 1–20